These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 19117662

  • 21. Inhibition of viral group-1 and group-2 neuraminidases by oseltamivir: A comparative structural analysis by the ScrewFit algorithm.
    Calligari PA, Kneller GR, Giansanti A, Ascenzi P, Porrello A, Bocedi A.
    Biophys Chem; 2009 Apr; 141(1):117-23. PubMed ID: 19195766
    [Abstract] [Full Text] [Related]

  • 22. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
    Singh A, Soliman ME.
    Drug Des Devel Ther; 2015 Apr; 9():4137-54. PubMed ID: 26257512
    [Abstract] [Full Text] [Related]

  • 23. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
    Liu H, Yao X, Wang C, Han J.
    Mol Pharm; 2010 Jun 07; 7(3):894-904. PubMed ID: 20420444
    [Abstract] [Full Text] [Related]

  • 24. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Udommaneethanakit T, Rungrotmongkol T, Bren U, Frecer V, Stanislav M.
    J Chem Inf Model; 2009 Oct 07; 49(10):2323-32. PubMed ID: 19780597
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A strategy for theoretical binding constant, Ki, calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuraminidase.
    Jedrzejas MJ, Singh S, Brouillette WJ, Air GM, Luo M.
    Proteins; 1995 Oct 07; 23(2):264-77. PubMed ID: 8592707
    [Abstract] [Full Text] [Related]

  • 27. Rational design of Tamiflu derivatives targeting at the open conformation of neuraminidase subtype 1.
    Li Y, Zhou B, Wang R.
    J Mol Graph Model; 2009 Oct 07; 28(3):203-19. PubMed ID: 19656699
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
    Takano R, Kiso M, Igarashi M, Le QM, Sekijima M, Ito K, Takada A, Kawaoka Y.
    J Infect Dis; 2013 Jan 01; 207(1):89-97. PubMed ID: 23053629
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The hydrophobic side chain of oseltamivir influences type A subtype selectivity of neuraminidase inhibitors.
    Lin X, Qin-Hua C, Peng L, Chun-Lei L, Guang-De Y.
    Chem Biol Drug Des; 2018 Jan 01; 91(1):105-115. PubMed ID: 28646621
    [Abstract] [Full Text] [Related]

  • 34. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.
    Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, Walker PA, Skehel JJ, Martin SR, Hay AJ, Gamblin SJ.
    Nature; 2008 Jun 26; 453(7199):1258-61. PubMed ID: 18480754
    [Abstract] [Full Text] [Related]

  • 35. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.
    Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, Blackburn GM, Hay AJ, Gamblin SJ, Skehel JJ.
    Nature; 2006 Sep 07; 443(7107):45-9. PubMed ID: 16915235
    [Abstract] [Full Text] [Related]

  • 36. A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.
    Chintakrindi AS, Martis EA, Gohil DJ, Kothari ST, Chowdhary AS, Coutinho EC, Kanyalkar MA.
    Curr Comput Aided Drug Des; 2016 Sep 07; 12(4):272-281. PubMed ID: 27412704
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.